3ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic[ J] .JAMA,2002,288:2981.
4Hansson L,Zanchetti A, Carruthers SG, et al. Effects of intensive bloodpressure lowering and low-dose aspirin in patients with hypertension:HOT randomized trial[ J]. Lancet, 1998,351 ( 9118): 1755.
6Jones DW, Hall JE. Seventh report of the Joint National Committee on Prevention,Detection, Evaluation and Treatment of High Blood Pressure and evidence from new hypertension trials [ J ]. Hypertension, 2004,43(1):1.
7Wing LM, Arnolda LF, Harvey PJ, et al. Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly[J]. J Hypertens, 1997,15( 12 Pt 1 ): 1503.
8Oparil S,Barr E,Elkins M, et al. Efficacy, tolerability, and effects on quality oflife of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension[ J]. Clin Ther, 1996,18(4) :608.
9Burris JF,Weir MR,Oparil S, et al. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy[ J]. JAMA, 1990, 263(11):1507.
1Omboni S, Parati G, Zanchetti A, et al. Calculation of trough-to-peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens, 1995, 13: 1105-1112.
2Meredith PA. Role of trough to peak efficacy in the evaluation of antihypertensive therapy. J Hypertens, 1998, 16(Suppl 1): s59-s64.
3Campbell MJ, Gardner MJ. Calculating confidence intervals for some non-parametric analyses. In: Gardner MJ, Altman DG, ets. Statistcs with confidence. London: Britishi Medical Journal, 1989. 71-79.
4T Morgan, J Menard, H Brunner. Trough to peak ratio as a guide to BP control: measurement and calculation. J Hum Hypertens, 1998, 12: 49-53.
5Mallion JM, Asmar R, Boutelant S, et al. Twenty-four hour antihypertensive efficacy of indapamide 1.5mg sustained release: results of two randomised double-blind controlled studies. J Cardiovasc Pharmacol, 1998, 32: 673-678.
